A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases

Dirk Rades, Stefan Janssen, Liesa Dziggel, Oliver Blanck, Amira Bajrovic, Theo Veninga, Steven E. Schild

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: This matched-pair study was initiated to validate the results of a retrospective study of 186 patients published in 2007 that compared whole-brain irradiation (WBI) alone and radiosurgery (RS) alone for up to three brain metastases. Methods: One-hundred-fifty-two patients receiving WBI alone for up to three brain metastases were matched with 152 patients treated with RS of fractionated stereotactic radiotherapy (FSRT) alone 1:1 for each of eight factors (age, gender, Eastern Oncology Cooperative Group (ECOG)-performance score, nature of tumor, brain metastases number, extra-cerebral spread, period from cancer detection to irradiation of brain metastases, and recursive partitioning analysis (RPA)-class. Groups were analyzed regarding intracerebral control (IC) and overall survival (OS). Results: On univariate analysis of IC, type of irradiation did not significantly affect outcomes (p=0.84). On Cox regression, brain metastases number (p<0.001), nature of tumor (p<0.001) and period from cancer detection to irradiation of brain metastases (p=0.013) were significantly associated with IC. On univariate analysis of OS, type of irradiation showed no significant association with outcomes (p=0.63). On multivariate analyses, OS was significantly associated with ECOG performance score (p=0.011), nature of tumor (p=0.035), brain metastases number (p=0.048), extra-cerebral spread (p=0.002) and RPA-class (p<0.001). Conclusion: In this matched-pair study, RS/FSRT alone was not superior to WBI alone regarding IC and OS. These results can be considered a revision of the findings from our retrospective previous study without matched-pair design, where RS alone resulted in significantly better IC than WBI alone on multivariate analysis.

Original languageEnglish (US)
Article number30
JournalBMC Cancer
Volume17
Issue number1
DOIs
StatePublished - Jan 6 2017

Fingerprint

Radiosurgery
Radiotherapy
Neoplasm Metastasis
Brain
Survival
Neoplasms
Multivariate Analysis
Retrospective Studies
Age Factors
Survival Analysis
Brain Neoplasms

Keywords

  • Intracerebral control
  • Matched-pair study
  • Metastases to the brain
  • Overall survival
  • Radiosurgery
  • Whole-brain irradiation

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this

A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases. / Rades, Dirk; Janssen, Stefan; Dziggel, Liesa; Blanck, Oliver; Bajrovic, Amira; Veninga, Theo; Schild, Steven E.

In: BMC Cancer, Vol. 17, No. 1, 30, 06.01.2017.

Research output: Contribution to journalArticle

Rades, Dirk ; Janssen, Stefan ; Dziggel, Liesa ; Blanck, Oliver ; Bajrovic, Amira ; Veninga, Theo ; Schild, Steven E. / A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases. In: BMC Cancer. 2017 ; Vol. 17, No. 1.
@article{4785110c10404cc68707cad6269cc60b,
title = "A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases",
abstract = "Background: This matched-pair study was initiated to validate the results of a retrospective study of 186 patients published in 2007 that compared whole-brain irradiation (WBI) alone and radiosurgery (RS) alone for up to three brain metastases. Methods: One-hundred-fifty-two patients receiving WBI alone for up to three brain metastases were matched with 152 patients treated with RS of fractionated stereotactic radiotherapy (FSRT) alone 1:1 for each of eight factors (age, gender, Eastern Oncology Cooperative Group (ECOG)-performance score, nature of tumor, brain metastases number, extra-cerebral spread, period from cancer detection to irradiation of brain metastases, and recursive partitioning analysis (RPA)-class. Groups were analyzed regarding intracerebral control (IC) and overall survival (OS). Results: On univariate analysis of IC, type of irradiation did not significantly affect outcomes (p=0.84). On Cox regression, brain metastases number (p<0.001), nature of tumor (p<0.001) and period from cancer detection to irradiation of brain metastases (p=0.013) were significantly associated with IC. On univariate analysis of OS, type of irradiation showed no significant association with outcomes (p=0.63). On multivariate analyses, OS was significantly associated with ECOG performance score (p=0.011), nature of tumor (p=0.035), brain metastases number (p=0.048), extra-cerebral spread (p=0.002) and RPA-class (p<0.001). Conclusion: In this matched-pair study, RS/FSRT alone was not superior to WBI alone regarding IC and OS. These results can be considered a revision of the findings from our retrospective previous study without matched-pair design, where RS alone resulted in significantly better IC than WBI alone on multivariate analysis.",
keywords = "Intracerebral control, Matched-pair study, Metastases to the brain, Overall survival, Radiosurgery, Whole-brain irradiation",
author = "Dirk Rades and Stefan Janssen and Liesa Dziggel and Oliver Blanck and Amira Bajrovic and Theo Veninga and Schild, {Steven E.}",
year = "2017",
month = "1",
day = "6",
doi = "10.1186/s12885-016-2989-3",
language = "English (US)",
volume = "17",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases

AU - Rades, Dirk

AU - Janssen, Stefan

AU - Dziggel, Liesa

AU - Blanck, Oliver

AU - Bajrovic, Amira

AU - Veninga, Theo

AU - Schild, Steven E.

PY - 2017/1/6

Y1 - 2017/1/6

N2 - Background: This matched-pair study was initiated to validate the results of a retrospective study of 186 patients published in 2007 that compared whole-brain irradiation (WBI) alone and radiosurgery (RS) alone for up to three brain metastases. Methods: One-hundred-fifty-two patients receiving WBI alone for up to three brain metastases were matched with 152 patients treated with RS of fractionated stereotactic radiotherapy (FSRT) alone 1:1 for each of eight factors (age, gender, Eastern Oncology Cooperative Group (ECOG)-performance score, nature of tumor, brain metastases number, extra-cerebral spread, period from cancer detection to irradiation of brain metastases, and recursive partitioning analysis (RPA)-class. Groups were analyzed regarding intracerebral control (IC) and overall survival (OS). Results: On univariate analysis of IC, type of irradiation did not significantly affect outcomes (p=0.84). On Cox regression, brain metastases number (p<0.001), nature of tumor (p<0.001) and period from cancer detection to irradiation of brain metastases (p=0.013) were significantly associated with IC. On univariate analysis of OS, type of irradiation showed no significant association with outcomes (p=0.63). On multivariate analyses, OS was significantly associated with ECOG performance score (p=0.011), nature of tumor (p=0.035), brain metastases number (p=0.048), extra-cerebral spread (p=0.002) and RPA-class (p<0.001). Conclusion: In this matched-pair study, RS/FSRT alone was not superior to WBI alone regarding IC and OS. These results can be considered a revision of the findings from our retrospective previous study without matched-pair design, where RS alone resulted in significantly better IC than WBI alone on multivariate analysis.

AB - Background: This matched-pair study was initiated to validate the results of a retrospective study of 186 patients published in 2007 that compared whole-brain irradiation (WBI) alone and radiosurgery (RS) alone for up to three brain metastases. Methods: One-hundred-fifty-two patients receiving WBI alone for up to three brain metastases were matched with 152 patients treated with RS of fractionated stereotactic radiotherapy (FSRT) alone 1:1 for each of eight factors (age, gender, Eastern Oncology Cooperative Group (ECOG)-performance score, nature of tumor, brain metastases number, extra-cerebral spread, period from cancer detection to irradiation of brain metastases, and recursive partitioning analysis (RPA)-class. Groups were analyzed regarding intracerebral control (IC) and overall survival (OS). Results: On univariate analysis of IC, type of irradiation did not significantly affect outcomes (p=0.84). On Cox regression, brain metastases number (p<0.001), nature of tumor (p<0.001) and period from cancer detection to irradiation of brain metastases (p=0.013) were significantly associated with IC. On univariate analysis of OS, type of irradiation showed no significant association with outcomes (p=0.63). On multivariate analyses, OS was significantly associated with ECOG performance score (p=0.011), nature of tumor (p=0.035), brain metastases number (p=0.048), extra-cerebral spread (p=0.002) and RPA-class (p<0.001). Conclusion: In this matched-pair study, RS/FSRT alone was not superior to WBI alone regarding IC and OS. These results can be considered a revision of the findings from our retrospective previous study without matched-pair design, where RS alone resulted in significantly better IC than WBI alone on multivariate analysis.

KW - Intracerebral control

KW - Matched-pair study

KW - Metastases to the brain

KW - Overall survival

KW - Radiosurgery

KW - Whole-brain irradiation

UR - http://www.scopus.com/inward/record.url?scp=85008354882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008354882&partnerID=8YFLogxK

U2 - 10.1186/s12885-016-2989-3

DO - 10.1186/s12885-016-2989-3

M3 - Article

C2 - 28061768

AN - SCOPUS:85008354882

VL - 17

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 1

M1 - 30

ER -